Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women.N Engl J Med. 2001; 345: 561-567
- Women’s knowledge about intrauterine contraception.Obstet Gynecol. 2011; 117: 48-54
- Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists’ knowledge and attitudes.Contraception. 2010; 81: 112-116
- The fog zone: how misperceptions, magical thinking, and ambivalence put young adults at risk for unplanned pregnancy.National Campaign to Prevent Teen and Unplanned Pregnancy, Washington, DC2009
- ‘But you can’t reverse a hysterectomy!’ Perceptions of long acting reversible contraception (LARC) among young women aged 16-24 years: a qualitative study.Public Health. 2014; 128: 934-939
- Fear of intrauterine contraception among adolescents in New York City.Contraception. 2014; 89: 446-450
- Fertility after intrauterine device removal: a pilot study.Eur J Contracept Reprod Health Care. 2015; 20: 223-230
- Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.Lancet. 1980; 1: 509-512
Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Wiley Series in Probability and Statistics. Hoboken, NJ: John Wiley & Sons, Inc; 2002.
- Racial and ethnic disparities in assisted reproductive technology pregnancy and live birth rates within body mass index categories.Fertil Steril. 2011; 95: 1661-1666
- Racial differences in self-reported infertility and risk factors for infertility in a cohort of black and white women: the CARDIA Women’s Study.Fertil Steril. 2008; 90: 1640-1648
- Adverse effects of female obesity and interaction with race on reproductive potential.Fertil Steril. 2017; 107: 868-877
- Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.Sex Transm Dis. 1992; 19: 185-192
- Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial.Obstet Gynecol. 2000; 95: 397-402
- Proportion of pelvic inflammatory disease cases caused by Chlamydia trachomatis: consistent picture from different methods.J Infect Dis. 2016; 214: 617-624
- Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study among primary care patients.Clin Infect Dis. 2019; 69: 1517-1525
- Mycoplasma genitalium serum antibodies in infertile couples and fertile women.Sex Transm Infect. 2015; 91: 589-591
- Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.Sex Transm Infect. 2008; 84: 338-342
- Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception.BJOG. 2001; 108: 304-314
J.F.P. serves on Advisory Boards for Bayer and CooperSurgical. He has received research support from CooperSurgical, Merck, and Bayer. C.A.S., The University of Pennsylvania has received research funding from Bayer Healthcare, Sebela, Medicines360 and NIH. S.T., The University of Colorado Department of Obstetrics and Gynecology has received research funding from Bayer Healthcare, Sebela, Agile Therapeutics, Merck & Co, and Medicines360. S.T. has served on a scientific advisory board for Bayer Healthcare and a data safety and monitoring board for a product marketed by Merck & Co. D.K.T. serves as a consultant for Sebela Pharmaceuticals, Inc. The University of Utah, Division of Family Planning, receives research funding from Bayer Women’s Health Care; Merck & Co, Inc; CooperSurgical; Bioceptive; Sebela Pharmaceuticals; and Medicines360. M.N. serves as a consultant for the Foundation Consumer Healthcare.
Funding for the Fertility After Contraceptive Termination Study was provided by the Society for Family Planning, CooperSurgical, and Bayer. Funding from all sponsors supported staff salaries for the enrollment and follow-up of all participants. Study design, protocol, procedures, statistical analysis, and so on, were all under the direction of the investigators and independent of the funders.
Cite this article as: Peipert JF, Zhao Q, Schreiber CA, et al. Intrauterine device use, sexually transmitted infections, and fertility: a prospective cohort study. Am J Obstet Gynecol 2021;225:157.e1-9.